Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol

Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol

Abstract Background Recent studies demonstrated the efficacy of S-1-based adjuvant chemotherapy administered for six months after curative surgery for stage III gastric cancer; however, it is unproven whether this type of combination chemotherapy is more effective than the standard adjuvant chemothe...

Full description

Bibliographic Details
Main Authors: Tsutomu Namikawa, Hiromichi Maeda, Hiroyuki Kitagawa, Koji Oba, Akihito Tsuji, Takaki Yoshikawa, Michiya Kobayashi, Kazuhiro Hanazaki
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Cancer
Subjects:
Gastric cancer
Adjuvant chemotherapy
Gastrectomy
Oxaliplatin
S-1
Clinical trial
Online Access:http://link.springer.com/article/10.1186/s12885-018-4109-z

Internet

http://link.springer.com/article/10.1186/s12885-018-4109-z

Similar Items